Robert Nelsen - Mar 22, 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Mar 22, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 08:55 PM
Next filing
May 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Other $0 -500K -4.69% $0.00 10.2M Mar 22, 2021 Held by ARCH Venture Fund VIII, L.P. F1, F2, F3, F4
transaction DNLI Common Stock Other $0 -500K -4.92% $0.00 9.67M May 12, 2021 Held by ARCH Venture Fund VIII, L.P. F1, F2, F3, F5
transaction DNLI Common Stock Other $0 +2.54K +125.02% $0.00 4.57K Mar 22, 2021 Direct F1, F2
transaction DNLI Common Stock Other $0 +2.54K +55.54% $0.00 7.11K May 12, 2021 Direct F1, F2
transaction DNLI Common Stock Options Exercise $0 +3.25K +45.78% $0.00 10.4K Jun 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNLI Restricted Stock Units Options Exercise $0 -3.25K -100% $0.00* 0 Jun 1, 2021 Common Stock 3.25K Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 Reflects change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
F3 The sole general partner of ARCH Venture Fund VIII, L.P. ("ARCH Fund VIII") is ARCH Venture Partners VIII, L.P. ("ARCH Partners VIII"). The sole general partner of ARCH Partners VIII is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"). ARCH Partners VIII may therefore be deemed to beneficially own the securities held by ARCH Fund VIII and ARCH VIII LLC may be deemed to beneficially own the securities held by ARCH Fund VIII. ARCH Partners VIII and ARCH VIII LLC disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein. The Reporting Person is a managing director of ARCH VIII LLC and may be deemed to beneficially own the shares held by ARCH Fund VIII. Mr. Nelsen disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
F4 Following the reported transactions, 10,168,749 shares of common stock were held of record by ARCH Fund VIII.
F5 Following the reported transactions, 9,668,749 shares of common stock were held of record by ARCH Fund VIII.
F6 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
F7 100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.